Sorafenib cardiotoxicity increases mortality after myocardial infarction.
Duran JM, Makarewich CA, Trappanese D, Gross P, Husain S, Dunn J, Lal H, Sharp TE, Starosta T, Vagnozzi RJ, Berretta RM, Barbe M, Yu D, Gao E, Kubo H, Force T, Houser SR.
Duran JM, et al. Among authors: lal h.
Circ Res. 2014 May 23;114(11):1700-1712. doi: 10.1161/CIRCRESAHA.114.303200. Epub 2014 Apr 9.
Circ Res. 2014.
PMID: 24718482
Free PMC article.